Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: Requirement of calcium/calmodulin-dependent protein kinase II

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 4, 2009, Pages

  Meoli, David F ^a   White, R James ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Fibronectin; Plexiform lesions; Pulmonary hypertension

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; COLLAGEN; ENDOTHELIN 1; FIBRONECTIN; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PEPTIDE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 1 AGONIST PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1 ANTAGONIST; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 2 AGONIST PEPTIDE; SCH 79797; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMIDE; SERYLPHENYLALANYLLEUCYLLEUCYLARGINYLASPARAGININAMIDE; SPHINGOSINE 1 PHOSPHATE; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOPLASTIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ENDOTHELIUM; MALE; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; PULMONARY MICROVASCULAR ENDOTHELIAL CELL; RAT; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBRONECTINS; HEMOSTATICS; OLIGOPEPTIDES; PULMONARY ARTERY; RATS; RECEPTOR, PAR-1; THROMBIN; WOUND HEALING;

EID: 70349768151     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90598.2008     Document Type: Article

References (68)

1. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445-450, 1994. (Pubitemid 24307211)
2. Alvarez DF, Huang L, King JA, ElZarrad MK, Yoder MC, Stevens T. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am J Physiol Lung Cell Mol Physiol 294: L419-L430, 2008.
3. Andersen R, Li Y, Resseguie M, Brenman JE. Calcium/calmodulin-dependent protein kinase II alters structural plasticity and cytoskeletal dynamics in Drosophila. J Neurosci 25: 8878-8888, 2005. (Pubitemid 41384455)
4. Borbiev T, Verin AD, Birukova A, Liu F, Crow MT, Garcia JG. Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 285: L43-L54, 2003. (Pubitemid 36736467)
5. Borbiev T, Verin AD, Shi S, Liu F, Garcia JG. Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol 280: L983-L990, 2001. (Pubitemid 32436064)
6. Bouvard D, Molla A, Block MR. Calcium/calmodulin-dependent protein kinase II controls alpha 5 beta 1 integrin-mediated inside-out signaling. J Cell Sci 111: 657-665, 1998. (Pubitemid 28142370)
7. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97: 5255-5260, 2000. (Pubitemid 30313705)
8. Cheng YF, Clyman RI, Enenstein J, Waleh N, Pytela R, Kramer RH. The integrin complex alpha v beta 3 participates in the adhesion of microvascular endothelial cells to fibronectin. Exp Cell Res 194: 69-77, 1991. (Pubitemid 121006247)
9. Clark J, Alvarez DF, Alexeyev M, King JAC, Huang L, Yoder MC, Stevens T. Regulatory role for nucleosome assembly protein-1 in the proliferative and vasculogenic phenotype of pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 294: L431-L439, 2008.
10. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 155: 411-419, 1999. (Pubitemid 29370391)
11. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 86: 298-307, 2001.
12. Cowan KN, Jones PL, Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105: 21-34, 2000. (Pubitemid 30036384)
13. Danen EH, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A. The fibronectin-binding integrins alpha 5 beta 1 and alpha v beta 3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell Biol 159: 1071-1086, 2002. (Pubitemid 36055761)
14. Dufourcq P, Couffinhal T, Alzieu P, Daret D, Moreau C, Duplaa C, Bonnet J. Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation. Cardiovasc Res 53: 953-963, 2002. (Pubitemid 34261033)
15. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA. Integrin alpha v beta 3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140: 1255-1263, 1998. (Pubitemid 28128883)
16. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665, 2004.
17. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30: 260-268, 2003. (Pubitemid 36152587)
18. Fishman AP. Etiology and pathogenesis of primary pulmonary hypertension: a perspective. Chest 114: 242S-247S, 1998.
19. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18, 2002.
20. Folkman J, Shing Y. Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
21. Fujii H, Nishikawa N, Komazawa H, Orikasa A, Ono M, Itoh I, Murata J, Azuma I, Saiki I. Inhibition of tumor invasion and metastasis by peptidic mimetics of Arg-Gly Asp (RGD) derived from the cell recognition site of fibronectin. Oncol Res 8: 333-342, 1996. (Pubitemid 27009736)
22. Gebb S, Stevens T. On lung endothelial cell heterogeneity. Microvasc Res 68: 1-12, 2004.
23. Giancotti FG. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 9: 691-700, 1997. (Pubitemid 27424926)
24. Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88: 1924-1932, 1991.
25. Hocking DC, Sottile J, McKeown-Longo PJ. Activation of distinct alpha 5 beta 1-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains. J Cell Biol 141: 241-253, 1998. (Pubitemid 28182655)
26. Hoshiga M, Alpers CE, Smith LL, Giachelli CM, Schwartz SM. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res 77: 1129-1135, 1995.
27. Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 91: 877-887, 2002.
28. Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, Courtman DW, Ezban M, Ellis SG, Topol EJ. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 92: 3041-3050, 1995.
29. Jones PL, Cowan KN, Rabinovitch M. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150: 1349-1360, 1997. (Pubitemid 27152653)
30. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A, Griffin C, Coughlin SR. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102: 3224-3231, 2003. (Pubitemid 37314759)
31. Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, Rosenzweig EB, Kerstein D, Barst RJ. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95: 199-203, 2005. (Pubitemid 40092084)
32. Keller R. Shaping the vertebrate body plan by polarized embryonic cell movements. Science 298: 1950-1954, 2002.
33. 2+ and permeability. Am J Physiol Lung Cell Mol Physiol 274: L810-L819, 1998.
34. Kim S, Harris M, Varner JA. Regulation of integrin alpha v beta 3-mediated endothelial cell migration and angiogenesis by integrin alpha 5 beta 1 and protein kinase A. J Biol Chem 275: 33920-33928, 2000.
35. King J, Hamil T, Creighton J, Wu S, Bhat P, McDonald F, Stevens T. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 67: 139-151, 2004. (Pubitemid 38327000)
36. Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res 100: 782-794, 2007.
37. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 84: 359-369, 1996.
38. 2+/ calmodulin- dependent protein kinase IV. J Cell Biochem 95: 1214-1223, 2005.
39. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101: 927-934, 1998.
40. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989. (Pubitemid 20066716)
41. Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3: 175-190, 2002. (Pubitemid 135706588)
42. Lobb RR, Hemler ME. The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 94: 1722-1728, 1994. (Pubitemid 2150008)
43. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB, Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 91: 2253-2259, 1993. (Pubitemid 23141502)
44. Mawatari K, Liu B, Kent KC. Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction. J Vasc Surg 31: 375-381, 2000. (Pubitemid 30100046)
45. Melchers F, Rolink AG, Schaniel C. The role of chemokines in regulating cell migration during humoral immune responses. Cell 99: 351-354, 1999.
46. Merklinger SL, Jones PL, Martinez EC, Rabinovitch M. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 112: 423-431, 2005. (Pubitemid 41022085)
47. Meyrick B. The pathology of pulmonary artery hypertension. Clin Chest Med 22: 393-404, 2001.
48. Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL, Trejo J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66: 307-314, 2006. (Pubitemid 43166037)
49. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999. (Pubitemid 29038270)
50. Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, Morse JH, Nichols WC, Rabinovitch M, Rodman DM, Stevens T, Tuder RM, Voelkel NF, Gail DB. Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop. Circulation 109: 2947-2952, 2004. (Pubitemid 38808315)
51. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 385: 537-540, 1997.
52. Parent CA, Devreotes PN. A cell's sense of direction. Science 284: 765-770, 1999.
53. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30-33, 1984. (Pubitemid 14134132)
54. Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Levy PS, Reid LM, Vreim CE, Williams GW. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the NHLBI Primary Pulmonary Hypertension Registry. Circulation 80: 1198-1206, 1989. (Pubitemid 19282508)
55. Pyo RT, Sato Y, Mackman N, Taubman MB. Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration. Thromb Haemost 92: 451-458, 2004. (Pubitemid 39248001)
56. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 302: 1704-1709, 2003. (Pubitemid 37505725)
57. Schweigerer L. Fibroblast growth factor and angiogenesis. Z Kardiol 78, Suppl 6: 12-15, 1989.
58. 2+/calmodulin- dependent protein kinase II-mediated actin reorganization. J Neurosci 26: 1813-1822, 2006.
59. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
60. Soderling TR. CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol 10: 375-380, 2000.
61. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta 1654: 13-22, 2004.
62. Trikha M, Zhou Z, Timar J, Raso E, Kennel M, Emmell E, Nakada MT. Multiple roles for platelet GPIIb/IIIa and alpha v beta 3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 62: 2824-2833, 2002. (Pubitemid 34525767)
63. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, Voelkel NF. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195: 367-374, 2001.
64. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144: 275-285, 1994. (Pubitemid 24165948)
65. Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S. Pathology of pulmonary hypertension. Clin Chest Med 28: 23-42, 2007.
66. White RJ, Meoli DF, Swarthout R, Kallop DY, Galaria II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD, Taubman MB. Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293: L583-L590, 2007. (Pubitemid 47358820)
67. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 91: 25-31, 2002. (Pubitemid 34778938)
68. Zhang X, Groopman JE, Wang JF. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha 5 beta 1. J Cell Physiol 202: 205-214, 2005 (Pubitemid 39603377)